Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMS 2023 | Current approaches to treating and managing MGUS

In this video, Nelson Leung, MD, Mayo Clinic, Rochester, MN, explains that patients with monoclonal gammopathy of undetermined significance (MGUS) are treated and managed with close observation, and further highlights current research looking to identify biomarkers of progression. This interview took place at the 20th International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.